Results 41 to 50 of about 17,726,149 (248)

Acknowledgement to Reviewers of Reports in 2019

open access: yesReports, 2020
The editorial team greatly appreciates the reviewers who have dedicated their considerable time and expertise to the journal’s rigorous editorial process over the past 12 months, regardless of whether the papers are finally published or not [...]
Reports Editorial Office
doaj   +1 more source

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta   +6 more
wiley   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli   +3 more
wiley   +1 more source

Editorial – Wisdom of the Crowds: Extending the Domain of Medical Information to Case Banks and Online Forums

open access: yesJournal of Orthopaedic Case Reports, 2013
As Evident in earlier Editorials [1,2,3], we at JOCR are striving for a bette understanding at Clinical Decision Making and better A Patient Care. Human deliberations and Single observations have been highlighted as important concepts in building a ...
Ashok Shyam
doaj   +1 more source

Increased Risk of Sarcomas in Children With Congenital Anomalies: Findings From the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Registry Linkage Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters   +17 more
wiley   +1 more source

Heavy and extreme rainfall in Makkah Region of Saudi Arabia at the present climate

open access: yesDiscover Sustainability
In recent decades, the frequency and intensity of rainfall have increased in the Makkah region of western Saudi Arabia, leading to flash floods. The sparse network of surface observation stations is inadequate to fully capture the rainfall dynamics in ...
Arjan O. Zamreeg   +5 more
doaj   +1 more source

Only Rare Cases are Case Reports: Busting a Myth

open access: yesJournal of Orthopaedic Case Reports, 2014
Being the editor of Journal of Orthopaedic Case Reports, I encounter a variety of queries and questions regarding the nature of Case Reports. Often when I point that a particular case can be presented as a case report, I get a reply that it is not a rare
Ashok Shyam
doaj   +1 more source

Supporting Survivor‐Centered Care Through Digital Health Integration

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Survivors of childhood cancer face barriers to receiving guideline‐based, long‐term follow‐up care. Two digital tools, Passport for Care (PFC) and Cancer SurvivorLink (SurvivorLink), address complementary gaps by enabling tailored survivorship care plan (SCP) generation, updating, storage, and sharing.
Jordan G. Marchak   +15 more
wiley   +1 more source

A look back at our first year

open access: yesCell Reports Medicine, 2021
Sara Hamilton   +4 more
doaj   +1 more source

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Home - About - Disclaimer - Privacy